Cargando…
Potential Repurposed Drug Candidates for Tuberculosis Treatment: Progress and Update of Drugs Identified in Over a Decade
[Image: see text] The devastating impact of Tuberculosis (TB) has been a menace to mankind for decades. The World Health Organization (WHO) End TB Strategy aims to reduce TB mortality up to 95% and 90% of overall TB cases worldwide, by 2035. This incessant urge will be achieved with a breakthrough i...
Autores principales: | Sharma, Khushbu, Ahmed, Faraz, Sharma, Tarina, Grover, Abhinav, Agarwal, Meetu, Grover, Sonam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210030/ https://www.ncbi.nlm.nih.gov/pubmed/37251185 http://dx.doi.org/10.1021/acsomega.2c05511 |
Ejemplares similares
-
Long-range replica exchange molecular dynamics guided drug repurposing against tyrosine kinase PtkA of Mycobacterium tuberculosis
por: Nagpal, Priya, et al.
Publicado: (2020) -
PGRS Domain of Rv0297 of Mycobacterium tuberculosis Is Involved in Modulation of Macrophage Functions to Favor Bacterial Persistence
por: Sharma, Tarina, et al.
Publicado: (2020) -
An immunoinformatics approach to design a multi-epitope vaccine against Mycobacterium tuberculosis exploiting secreted exosome proteins
por: Sharma, Rahul, et al.
Publicado: (2021) -
Author Correction: An immunoinformatics approach to design a multi-epitope vaccine against Mycobacterium tuberculosis exploiting secreted exosome proteins
por: Sharma, Rahul, et al.
Publicado: (2021) -
Computational models for the prediction of adverse cardiovascular drug reactions
por: Jamal, Salma, et al.
Publicado: (2019)